Choosing Wisely in endometrial & cervix cancers: Medical therapy

McVie-Veronesi Award Lecture “The quest to deliver a balance between the best care and Choosing Wisely”

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer

Immunotherapy resistance pathways investigated to tailor combination NSCLC therapy

ESMO 2024: Latest in EGFR mutated NSCLC

Understanding the use of PARPi combinations to treat patients with mCRPC

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Addressing the rise of multiple myeloma in Rwanda

Biomarkers, predictive and prognostic factors of resistance to immunotherapy

Hormonal receptor positive breast cancer adjuvant and metastatic indications

Pancreatic, hepatic and biliary malignancies

Updates on triple negative breast cancer and immunotherapy